Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Ginkgo Bioworks Holdings, Inc. Class A Common Stock (NY:DNA)

6.385 -0.225 (-3.40%)
Streaming Delayed Price Updated: 3:22 PM EDT, Mar 10, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Ginkgo Bioworks Holdings, Inc. Class A Common Stock

< Previous 1 2
...
8 9 10 11 12 13 14 15 Next >
News headline image
Ginkgo Bioworks Announces Acquisition Of Massachusetts COVID-19 Testing Provider Project Beacon COVID-19 LLC; Terms Not Disclosed ↗
Acquisition to enable Ginkgo to bolster its growing biosecurity platform and provide expanded COVID-19 testing options to communities in Massachusetts and beyond BOSTON, Jan. 19,... 
Via Benzinga
News headline image
Why Ginkgo Bioworks Shares Are Trading Higher Today ↗
Ginkgo Bioworks Holdings Inc (NYSE: DNA) is trading higher Wednesday after the company reported preliminary unaudited 2021 revenue highlights and a business review. Ginkgo... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
Gainers Absci (NASDAQ:ABSI) shares increased by 51.5% to $9.3 during Friday's pre-market session. The market value of their outstanding shares is at $861.1 million.... 
Via Benzinga
News headline image
10 Health Care Stocks Whale Activity In Today's Session ↗
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's Intraday Session ↗
Gainers Celyad Oncology (NASDAQ:CYAD) stock moved upwards by 32.58% to $4.72 during Friday's regular session. Trading volume for this security as of 12:30 EST is 45.2... 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For January 7, 2022 ↗
Upgrades According to Wolfe Research, the prior rating for CVR Energy Inc (NYSE: 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Wednesday ↗
Before 10 am on Wednesday, 99 companies set new 52-week lows. Facts of Interest About Today's 52-Week Lows: Sea (NYSE:SE) was the largest firm by market cap to set a... 
Via Benzinga
News headline image
Stocks Hitting New 52-Week Lows Today ↗
On Monday morning, 60 companies achieved new lows for the year. Points of Interest From Today's 52-Week Lows And Highs: Ginkgo Bioworks Holdings (NYSE:DNA) was... 
Via Benzinga
News headline image
41 Stocks Moving In Friday's Mid-Day Session ↗
Gainers IO Biotech, Inc. (NASDAQ: IOBT) jumped 42% to $11.74. The company, last month, priced its IPO at $14 per share. Celyad Oncology SA (NASDAQ: CYAD) shares jumped 38.7% to... 
Via Benzinga
Topics Initial Public Offering
News headline image
58 Biggest Movers From Friday ↗
Gainers Hagerty, Inc. (NYSE: HGTY) shares jumped 46.5% to close at $15.62. TuanChe Limited (NASDAQ: TC) gained 44.7% to settle at $3.30. IO Biotech, Inc. (NASDAQ: IOBT) shares... 
Via Benzinga
News headline image
48 Biggest Movers From Yesterday ↗
Gainers Xiaobai Maimai Inc. (NASDAQ: HX) shares surged 98.4% to settle at $18.87 on Wednesday on above-average volume. The company on Tuesday disclosed the resignation of its CEO... 
Via Benzinga
News headline image
Why Shares of Ginkgo Bioworks Plunged Today ↗
A new project in the Lone Star state wasn't enough to convince the bears to hold on to their shares. 
Via The Motley Fool
News headline image
32 Stocks Moving In Wednesday's Mid-Day Session ↗
Gainers Sesen Bio, Inc. (NASDAQ: SESN) rose 34.7% to $1.36. The FDA granted Sesen Bio’s request for a Type A meeting to discuss the Chemistry, Manufacturing, and Controls (... 
Via Benzinga
News headline image
Mid-Afternoon Market Update: Dow Surges Over 100 Points; Harmony Biosciences Shares Spike Higher ↗
Toward the end of trading Tuesday, the Dow traded up 0.33% to 35,374.03 while the NASDAQ rose 0.54% to 15,103.67. The S&P also rose, gaining 0.55% to 4,511.35. The U.S. has... 
Via Benzinga
Topics Stocks
News headline image
52 Biggest Movers From Yesterday ↗
Gainers Xiaobai Maimai Inc. (NASDAQ: HX) shares climbed 42.6% to close at $9.51 on Tuesday. Xiaobai Maimai said Xiaobao An resigned as CEO. Kaival Brands Innovations Group... 
Via Benzinga
News headline image
44 Biggest Movers From Yesterday ↗
Gainers Benessere Capital Acquisition Corp. (NASDAQ: BENER) shares jumped 66.5% to close at $0.4530 on Thursday. Grove, Inc. (NASDAQ: GRVI) gained 39.3% to close at $6.98 after... 
Via Benzinga
News headline image
Ginkgo Bioworks Price Predictions: Why One Analyst Thinks Hard-Hit DNA Stock Can Hit $14.50 ↗
Today, a bullish analyst price target placed on Ginkgo Bioworks has sent DNA stock on a nice ride as investors pile into this growth play. 
Via InvestorPlace
News headline image
Why Shares of Gingko Bioworks Are Skyrocketing Today ↗
Wall Street is waxing bullishly on this synbio start-up. 
Via The Motley Fool
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For October 13, 2021 ↗
Upgrades DA Davidson upgraded the previous rating for Columbia Banking System Inc (NASDAQ: 
Via Benzinga
News headline image
Never Mind Ginkgo Bioworks' Drama -- This Synthetic Biology Stock Is Still a Buy ↗
If the latest short-seller attack on Ginkgo Bioworks has you nervous about synthetic biology, consider the industry leader. 
Via The Motley Fool
News headline image
DNA Stock: The Bull Call That Has Ginkgo Bioworks Bouncing Back After Last Week’s “Scam” Accusation ↗
Ginkgo Bioworks (DNA) stock is doing well on Tuesday as it recovers with new coverage from an analyst with a bull stance. 
Via InvestorPlace
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For October 12, 2021 ↗
Upgrades For Callaway Golf Co (NYSE:ELY), Compass ... 
Via Benzinga
News headline image
46 Biggest Movers From Yesterday ↗
Gainers Protagonist Therapeutics, Inc. (NASDAQ: PTGX) shares jumped 93.9% to close at $35.36 on Monday. The FDA removed the full clinical hold on Protagonist Therapeutics’... 
Via Benzinga
News headline image
28 Stocks Moving In Monday's Mid-Day Session ↗
Gainers Protagonist Therapeutics, Inc. (NASDAQ: PTGX) shares surged 85% to $33.78. The FDA removed the full clinical hold on Protagonist Therapeutics’ rusfertide clinical... 
Via Benzinga
News headline image
Cathie Wood's Ark Invest Piles Up Another $15.8M In Gingko On Dip Amid Short-Seller Allegations ↗
Cathie Wood-led Ark Invest on Friday snapped up more shares in Ginkgo Bioworks Holdings Inc (NYSE: DNA) on the dip. The popular money manager’s investment firm snapped up 1.... 
Via Benzinga
News headline image
40 Biggest Movers From Yesterday ↗
Gainers Volcon, Inc. (NASDAQ: VLCN) shares jumped 97.5% to settle at $10.86 on Wednesday as the company priced its IPO at $5.50 per share. Voyager Therapeutics, Inc. (NASDAQ:... 
Via Benzinga
Topics Initial Public Offering
News headline image
Cathie Wood Sells $49.4M In Tesla And Buys $87.5M In Ginkgo Bioworks On Dip As Stock Becomes Target Of Short Sellers ↗
Cathie Wood-led Ark Invest on Wednesday snapped up shares in Ginkgo Bioworks Holdings Inc (NYSE: DNA) on the day the synthetic biology company stock was hit hard by two back-to-... 
Via Benzinga
News headline image
DNA Stock: 7 Things to Know About the Short Report Hammering Ginkgo Bioworks ↗
Today, Ginko Bioworks and DNA stock are firmly in the sights of short-sellers as various claims are made about an elaborate fraud underway. 
Via InvestorPlace
Topics Fraud
News headline image
Ginkgo Bioworks Stock Drops 20% After Short Sellers Call Company A 'Colossal Scam' ↗
Shares of synthetic biology company Ginkgo Bioworks Holdings Inc (NYSE: 
Via Benzinga
News headline image
26 Stocks Moving In Wednesday's Mid-Day Session ↗
Gainers Voyager Therapeutics, Inc. (NASDAQ: VYGR) shares jumped 54.1% to $3.8050 after the company announced licensing option agreement with Pfizer for capsids generated from... 
Via Benzinga
< Previous 1 2
...
8 9 10 11 12 13 14 15 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.